A good CCR5 antagonists may pair well with these approved or soon approved AD drugs to provide a much better outcome. May even reverse the swelling, brain bleeding effect. Looking forward to the “investigator-initiated pilot study of leronlimab in patients with Alzheimer’s Disease, and a project that will evaluate the use of leronlimab in patients living with HIV who are undergoing stem cell transplantation in a proof of cure study.”

https://www.cytodyn.com/newsroom/press-releas...areholders